From: The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
Number of hospitalisations in the first 2 years
Major disability at 2 years
Number of hospitalisations with respiratory illness in the first 2 years
Death or major disability at 2 years